PIM
JAZZ icon

Platinum Investment Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Platinum Investment Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-452
Closed -$76.8K – 111
2025
Q4 		$76.8K Sell
452
-1,745
-79% -$268K 0.02% 98
2025
Q3 		$290K Sell
2,197
-158
-7% -$19K 0.02% 101
2025
Q2 		$250K Buy
2,355
+287
+14% +$31.2K 0.02% 103
2025
Q1 		$257K Buy
2,068
+1,348
+187% +$176K 0.01% 104
2024
Q4 		$88.7K Sell
720
-71
-9% -$8.37K 0.01% 94
2024
Q3 		$88.1K Sell
791
-139
-15% -$15.2K ﹤0.01% 114
2024
Q2 		$99.3K Buy
930
+109
+13% +$12K ﹤0.01% 124
2024
Q1 		$98.9K Buy
821
+124
+18% +$15.2K ﹤0.01% 129
2023
Q4 		$85.7K Hold
697
– – ﹤0.01% 134
2023
Q3 		$90.2K Hold
697
– – ﹤0.01% 127
2023
Q2 		$86.4K Buy
697
+81
+13% +$10.9K ﹤0.01% 132
2023
Q1 		$90.1K Buy
+616
New +$91.1K ﹤0.01% 127

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

Platinum Investment Management's JAZZ Position: Q1 2026 in Review

Platinum Investment Management sold out of Jazz Pharmaceuticals (JAZZ) in Q1 2026, closing a stake of 452 shares — an estimated $76.8K sold.

Platinum Investment Management first reported a position in JAZZ in Q1 2023 and held it in 12 quarters. The position peaked at $290K in Q3 2025. 574 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

  • Platinum Investment Management reported no remaining Jazz Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Platinum Investment Management sold 452 Jazz Pharmaceuticals shares in Q1 2026, an estimated $76.8K.
  • Platinum Investment Management first reported a position in Jazz Pharmaceuticals in Q1 2023 and held it in 12 quarters.
  • Platinum Investment Management's Jazz Pharmaceuticals position peaked at $290K in Q3 2025.
  • 574 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on Platinum Investment Management's 13F filing for Q1 2026, filed 14 May 2026.